Hypokalemia with venlafaxine [6]

Journal of Clinical Psychiatry

Volumn 63, Issue 11, 2002, Pages 1049-1050

  Shang, Chi Yung ^a   Soong, Wei Tsuen ^a   Lin, Hsin Nan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MAGNESIUM; MAGNESIUM SULFATE; POTASSIUM; POTASSIUM CHLORIDE; SODIUM CHLORIDE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE; ELECTROLYTE;

ADULT; CASE REPORT; DEPRESSION; DRUG WITHDRAWAL; GITELMAN SYNDROME; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; LETTER; MAGNESIUM BLOOD LEVEL; MALE; MUSCLE SPASM; PATHOPHYSIOLOGY; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; TETANY; VASOPRESSIN RELEASE; BLOOD; CHEMICALLY INDUCED DISORDER; MAGNESIUM DEFICIENCY; MIDDLE AGED; SCHWARTZ BARTTER SYNDROME;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DEPRESSIVE DISORDER; ELECTROLYTES; HUMANS; HYPOKALEMIA; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED;

EID: 0036826904     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n1116h     Document Type: Letter

References (6)

1. Preskorn SH. Antidepressant drug selection: Criteria and options. J Clin Psychiatry 1994;55(suppl A):6-22
2. Masood GR, Karki SD, Patterson WR. Hyponatremia with venlafaxine. Ann Pharmacother 1998;32:49-51
3. Inoue A, Bunag RD. Sympathetic inhibition and vasopressin mediation during centrally induced responses to serotonin in rats. Brain Res 1992;582:215-220
4. Rodriguez-Soriano J. Bartter and related syndromes: The puzzle is almost solved. Pediatr Nephrol 1998;12:315-327
5. Mastroianni N, Bettinelli A, Bianchetti M, et al. Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome. Am J Hum Genet 1996;59:1019-1026
6. Quamme GA. Renal magnesium handling: New insights in understanding old problems. Kidney Int 1997;52:1180-1195